Home/Filings/4/0001127602-22-028084
4//SEC Filing

Barnes Alane P 4

Accession 0001127602-22-028084

CIK 0000882796other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 4:43 PM ET

Size

6.8 KB

Accession

0001127602-22-028084

Insider Transaction Report

Form 4
Period: 2022-12-19
Barnes Alane P
VP, General Counsel & Corp Sec
Transactions
  • Award

    Emp. Stock Option (Right to Buy)

    2022-12-19+158,500158,500 total
    Exercise: $10.63From: 2023-12-19Exp: 2032-12-19Common Stock (158,500 underlying)
  • Award

    Common Stock

    2022-12-19+34,000232,770 total
Footnotes (2)
  • [F1]Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
  • [F2]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001584348

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:43 PM ET
Size
6.8 KB